Abstract: The present invention is directed to substituted N-heterocycle derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.
Type:
Grant
Filed:
October 12, 2004
Date of Patent:
June 23, 2009
Assignee:
Wyeth
Inventors:
Paige Erin Mahaney, Lori Krim Gavrin, Douglas John Jenkins
Abstract: This invention provides compounds of formula VI
wherein
Y is hydrogen, methyl, methoxy, methylthio or trifluoromethyl;
R is hydrogen, C1-3alkyl or (CH2)nAr;
n is 0, 1 or 2; and
Ar is phenyl or methoxyphenyl,
or a pharmaceutically acceptable salt thereof. These compounds are selective dopamine autoreceptor agonists useful in treating disease states involving hyperactivity of dopamine systems. The invention also comprises intermediate compounds, compositions and methods related to the compounds of formula VI.
Type:
Grant
Filed:
May 3, 2002
Date of Patent:
June 1, 2004
Assignee:
Wyeth
Inventors:
Lynne P. Greenblatt, Ivo Jirkovsky, Richard E. Mewshaw
Abstract: Compounds of formula (1) are provided:
wherein
R1 and R2 are H, OH, F, Cl, Br, I, 1 to 6 carbon alkyl or alkenyl, 1 to 6 carbon alkoxy, aryl, OR5, nitro, amino, CF3 or R1 and R2 are taken together to form a fused ring at the 2,3- or 3,4-positions providing a fused phenyl group or a benzodioxane group, or a 4- or 7-substituted indole group, or a 5- or 8-substituted quinoline group;
R3 represents a group selected from hydrogen, a 1 to 6 carbon alkyl, a 1 to 4 carbon alkoxy or a halogen;
R4 represents a group selected from hydrogen, 1 to 6 carbon alkyl or R5;
R5 is CH2Ph in which the phenyl ring can be optionally substituted by a group selected from OMe, halogen, CF3;
X is selected from a group represented by C, CR4, [[CHR4]] and CHCH2;
A is selected from a group represented by N, NH, CH and CH2;
B is selected from a group represented by ═O, ═S, H and H2;
or A and B may be concatenated together to form indole, benzimidazole, indolone or indoline moieties; o